ESH Video

2nd Translational Research Conference: Chronic Lymphocytic Leukaemia

2nd Translational Research Conference: Chronic Lymphocytic Leukaemia
March 17 - March 20, 2022 - E-CONFERENCE, #ESHCLL2022 - PROGRAMME ON-DEMAND AVAILABLE UNTIL APRIL 20, 2022
Chairs : Jennifer Brown, Paolo Ghia, Michael Hallek

Information

2nd Translational Research E-Conference 
Chronic Lymphocytic Leukaemia
March 17-20, 2022

#ESHCLL2022

Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

 

 


BREAKING NEWS!

In view of continuing COVID-19 related challenges and uncertainties,
the 2nd Translational Research Conference  ON Chronic Lymphocytic Leukaemia
will be held as a VIRTUAL EVENT.

The safety of our speakers and attendees comes first.
We successfully transformed our last 14 conferences into E-Conferences
and will place you in the best dispositions to enjoy the presentations and discussions.

Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme
at a convenient hour, registration will allow participants to join both
the LIVE PROGRAMME: March 17-20, 2022
and the PROGRAMME ON-DEMAND: March 8 – April 20, 2022

REGISTRATION IS OFFERED FREE OF CHARGE
as a gesture of solidarity during these difficult times.

REGISTRATION NOW OPEN!

 


 

About the Conference

The 2nd ESH TRANSLATIONAL RESEARCH CONFERENCE ON CHRONIC LYMPHOCYTIC LEUKAEMIA can now be held in person to achieve again scientific interactions that are the primary goal of our gathering. The Conference is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.

This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease.  Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.

SCIENTIFIC TOPICS:
Spectrum of CLL disease: MBL to Richter’s transformation
New insights in “old” biomarkers
Taking driver gene mutations to the next level
Beyond BcR: other microenvironmental stimuli
Time-limited therapy
Covalent BTK inhibitors
BTK and Bcl2 inhibitor resistance
Next generation therapies
The future: other targets

LEARNING OBJECTIVES:
Upon completion of this CME activity, participants should be able to:
Understand recent advances in elucidating the pathogenesis of CLL
Describe recent data on the use of prognostic/predictive factors
Become familiar with the decision-making process for the novel therapeutics for CLL
Understand emerging data on mechanisms of resistance to targeted agents in CLL
Understand the debate about how best to optimize CLL therapy in the future

THE PROGRAMME WILL INCLUDE:
Plenary Sessions
Panel Discussions
Simultaneous Meet the Expert Sessions
Mentored Poster Walks
Brief Oral Communications

This meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior biologists and clinicians (MD, PhD)
• Clinical residents still in-training
• Allied health care professionals

 

 

 

 

 

Programme

CLICK HERE TO ACCESS THE FINAL SCIENTIFIC PROGRAMME.

Participants will be joining us from all over the world and from different time zones.
To make sure that everyone has access to the full scientific programme at a convenient hour, registration will allow participants to join both:
- the LIVE PROGRAMME: March 17-20, 2022
- and the PROGRAMME ON-DEMAND: March 8 - April 20, 2022

Click here to access the on-demand programme

Abstract submission

SUBMISSION OF ABSTRACTS IS NOW CLOSED.

 

Abstracts guidelines:

– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)

– Maximum number of words: 500

– Your abstract will be submitted to the peer review procedure.

The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).

 

Symposia

Accommodation

N/A

 

Venue

CLICK HERE TO VISIT THE E-CONFERENCE PLATFORM!

 

Take a virtual tour of the E-Conference platform and make yourself at home:

Corporate partners

With the support of*:
 
 
Major E-Conference Partners
*******
 

 
 
Level 1 E-Conference Partners
*******
 
 
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Scholarships

Workshop

Educational Grants

Registration

The registration for the ESH 2nd Translational Research Conference on Chronic Lymphocytic Leukaemia is offered FREE OF CHARGE, as a gesture of solidarity during these difficult times.

REGISTRATION IS NOW OPEN!

 

Meet the Expert sessions: Registration fee: 20€
These sessions will be open to E-Conference academic biologists and clinicians registrants only. A maximum of 30 seats will be available in each session and pre-registration will therefore be required.

Register HereMEET THE EXPERT SESSIONS REGISTRATION